Lung mass lesion
Conditions
Interventions
Experimental group:Percutaneous lung ablation using a navigation robotic system
Sponsors
Anhui Chest Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged 18-80 years (inclusive), regardless of gender; 2. With clinical and imaging diagnosis of a lung mass lesion and the need for a percutaneous lung ablation; 3. With good compliance and cooperation in completing CT-guided percutaneous lung ablation and other requirements of this study; 4. Are able to voluntarily participate in the clinical trial and sign the informed consent form
Exclusion criteria
Exclusion criteria: 1. Patients with uncorrectable coagulation disorders or on anticoagulation therapy, or the last dose of bevacizumab was no more than 1 month apart; 2. Patients with bleeding tendencies; 3. Patients with severe cardiopulmonary insufficiency (e.g., severe pulmonary hypertension) or abnormal electrocardiogram within 1 week prior to surgery, presence of atrial fibrillation, severe myocardial ischemia or arrhythmia; 4. Patients with severe hepatic or renal insufficiency (glutamic aminotransferase (ALT) or glutamic oxalacetic aminotransferase (AST) > 5 times the upper limit of normal, alkaline phosphatase (ALP) > 5 times the upper limit of normal, total bilirubin (TBil) > 3 times the upper limit of normal, serum creatinine (Scr) > 178µmol/L ), combined with other clinical manifestations, as determined by the investigator; 5. Patients with severe emphysema, pulmonary bulla, pulmonary fibrosis, or chronic obstructive pulmonary disease that lung puncture is contraindicated; 6. Patients with suspected intrapulmonary cystic lesions, such as pulmonary encapsulopathy; 7. Pregnant or lactating women; 8. Patients using devices that are subject to electromagnetic interference (e.g., pacemakers) or implants that cause electromagnetic interference; 9. Patients with a previous medical history of allergy to enhanced CT contrast agents; 10. Patients with other contraindications for CT-guided percutaneous lung ablation or who are otherwise deemed unsuitable for enrollment by their physicians
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Average times of CT scans during puncture; | — |
Secondary
| Measure | Time frame |
|---|---|
| Success rate of positioning;Operation time of positioning;Aiming accuracy;Mean dose length product;Fuctional assessment; | — |
Countries
China
Contacts
Public ContactXuhong Min
Anhui Chest Hospital
Outcome results
None listed